Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
boston top stories
eli lilly
3
×
genentech
3
×
life sciences
national blog main
national top stories
roche
3
×
san francisco blog main
san francisco top stories
avapritinib
blueprint medicines
boston
cancer
deals
indiana blog main
indiana top stories
investing
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
selpercatinib
thyroid cancer
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
bill cassidy
biogen
boulder/denver blog main
boulder/denver top stories
What
drug
approval
blueprint
cancer
fda
latest
medicines
ret
address
alzheimer’s
approves
bio
candidate
carries
certain
companies
currently
designed
different
fail
gene
genetic
increases
marketing
muscle
pact
pass
pharmaceutical
plan
prescription
price
prices
raise
regulatory
review
roche
roundup
signature
signatures
start
Language
unset
Current search:
genentech
×
roche
×
" eli lilly "
×
photo
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More